Variables | Total (n = 42) | Matched cohort | Â | Â |
---|---|---|---|---|
cTACE (n = 21) | cTACE+MWA (n = 21) | p | ||
Age, mean ± SD | 59.0 ± 9.4 | 60.7 ± 9.9 | 57.3 ± 8.8 | 0.249 |
Sex, n (%) | Â | Â | Â | 1 |
 Female | 3 (7.1) | 2 (9.5) | 1 (4.8) |  |
 Male | 39 (92.9) | 19 (90.5) | 20 (95.2) |  |
HBV, n (%) | Â | Â | Â | 1 |
 No | 5 (11.9) | 3 (14.3) | 2 (9.5) |  |
 Yes | 37 (88.1) | 18 (85.7) | 19 (90.5) |  |
HCV, n (%) | Â | Â | Â | 1 |
 No | 39 (92.9) | 19 (90.5) | 20 (95.2) |  |
 Yes | 3 (7.1) | 2 (9.5) | 1 (4.8) |  |
AFP, n (%) | Â | Â | Â | 1 |
 <200ng/ml | 27 (64.3) | 14 (66.7) | 13 (61.9) |  |
 ≥200ng/ml | 15 (35.7) | 7 (33.3) | 8 (38.1) |  |
CP, n (%) | Â | Â | Â | 1 |
 A | 39 (92.9) | 19 (90.5) | 20 (95.2) |  |
 B | 3 (7.1) | 2 (9.5) | 1 (4.8) |  |
Tumor size, median (IQR) | 3.4 (3.1, 4.1) | 3.4 (3.1, 4.1) | 3.5 (3.2, 4.1) | 0.612 |
Portal hypertension, n (%) | Â | Â | Â | 1 |
 No | 19 (45.2) | 9 (42.9) | 10 (47.6) |  |
 Yes | 23 (54.8) | 12 (57.1) | 11 (52.4) |  |
PLT (×109/L), median | 91.0 (67.2, 138.5) | 88.0 (67.0, 137.0) | 98.0 (70.0, 139.0) | 0.772 |
TBIL (μmol/L), mean ± SD | 13.3 ± 5.7 | 13.9 ± 6.4 | 12.7 ± 5.0 | 0.512 |
CRE (μmol/L), mean ± SD | 66.6 ± 8.9 | 65.1 ± 8.6 | 68.0 ± 9.2 | 0.296 |
INR, mean ± SD | 1.1 ± 0.1 | 1.1 ± 0.1 | 1.1 ± 0.1 | 0.653 |